Insiders Sage Therapeutics, Inc.

Equities

SAGE

US78667J1088

Real-time Estimate Cboe BZX Other stock markets 20:38:24 27/06/2024 BST			5-day change	1st Jan Change
10.66 ^USD	-1.61%		-0.09%	-50.81%

06-20	JPMorgan Adjusts Price Target on Sage Therapeutics to $23 From $28, Maintains Overweight Rating	MT
06-12	Transcript : Sage Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 02:00 PM

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sage Therapeutics, Inc. Announces Not Standing for Re-Election of Board of Directors	04-24	CI
Sage Therapeutics, Inc. Announces Not Standing for Re-Election of Board of Directors	04-24	CI
Sage Therapeutics, Inc. Announces the Retirement of Steven Paul from the Board	03-26	CI
Sage Therapeutics, Inc. Announces Changes to Board of Directors	01-08	CI
Sage Therapeutics to Lay Off 40% Staff Amid Efforts to Support Financial Position	31/08/23	MT
Sage Therapeutics, Inc. Announces Management Changes	31/08/23	CI
Sage Therapeutics, Inc Appoints Jessica J. Federer to the Board	16/03/23	CI
Insider Sell: Sage Therapeutics	13/02/23	MT
Insider Buy: Sage Therapeutics	15/11/22	MT
Sage Therapeutics, Inc. Announces Resignation of Jeffrey M. Jonas as Chief Innovation Officer	08/11/22	CI
Sage Therapeutics Appoints Laura M. Gault as Chief Medical Officer	01/11/22	CI
Insider Buy: Sage Therapeutics	09/05/22	MT
Sage Therapeutics Appoints Mark Pollack as Senior Vice President, Medical Affairs	03/05/22	CI
Sage Therapeutics : Names Chris Benecchi as Chief Commercial Officer	21/09/21	MT
Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer	21/09/21	CI
Insider Trends: Sage Therapeutics Insider 90-Day Buying Trend Continued with Purchase	09/08/21	MT
Insider Trends: Insider Purchase Continues Sage Therapeutics Positive Trend	17/06/21	MT
Insider Trends: Insider Purchase of Sage Therapeutics Stock Extends 90-Day Positive Trend	17/06/21	MT
Sage Therapeutics, Inc. Announces Departure of Mike Cloonan as Chief Operating Officer, Effective May 3, 2021	16/03/21	CI
Sage Therapeutics : Names Barry Greene CEO	16/12/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Sage Therapeutics, Inc.

Equities

SAGE

US78667J1088

Insiders

Filters